PharmaEssentia Corporation (LUX:261280523)

PharmaEssentia Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 7, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	4,621	6,032	3,383	4,381	2,477	719
Market Cap Growth	-21.20%	78.30%	-22.77%	76.88%	244.49%	0.07%
Enterprise Value	4,048	5,449	2,800	4,274	2,462	612
Last Close Price	13.89	18.14	10.20	-	-	-
PE Ratio	34.40	69.04	-	-	-	-
PS Ratio	11.96	21.03	22.44	49.91	118.91	44.34
PB Ratio	5.56	7.45	4.78	11.85	18.37	6.30
P/TBV Ratio	5.60	7.53	4.84	12.08	19.50	6.68
P/FCF Ratio	54.64	121.51	-	-	-	-
P/OCF Ratio	38.31	80.38	-	-	-	-
EV/Sales Ratio	10.56	19.00	18.58	48.69	118.21	37.73
EV/EBITDA Ratio	34.33	100.14	-	-	-	-
EV/EBIT Ratio	37.37	106.51	-	-	-	-
EV/FCF Ratio	47.85	109.75	-	-	-	-
Debt / Equity Ratio	0.03	0.04	0.05	0.13	0.13	0.17
Debt / EBITDA Ratio	0.21	0.47	-	-	-	-
Debt / FCF Ratio	0.30	0.57	-	-	-	-
Asset Turnover	0.43	0.33	0.24	0.27	0.11	0.13
Inventory Turnover	1.22	0.86	0.48	0.83	0.60	1.15
Quick Ratio	6.45	9.34	9.86	4.37	2.80	3.37
Current Ratio	6.83	9.94	10.64	5.24	3.49	3.82
Return on Equity (ROE)	17.21%	11.54%	-3.46%	-16.77%	-68.81%	-63.10%
Return on Assets (ROA)	7.68%	3.72%	-5.61%	-11.77%	-30.08%	-25.26%
Return on Capital (ROIC)	8.46%	4.05%	-6.16%	-13.71%	-37.72%	-29.60%
Return on Capital Employed (ROCE)	12.80%	6.10%	-	-	-	-
Earnings Yield	2.91%	1.45%	-0.54%	-0.96%	-3.60%	-7.88%
FCF Yield	1.83%	0.82%	-1.74%	-1.26%	-3.24%	-6.22%
Dividend Yield	0.12%	0.16%	-	-	-	-
Buyback Yield / Dilution	-0.44%	-3.59%	-13.47%	-9.24%	-7.39%	-10.55%
Total Shareholder Return	-0.32%	-3.43%	-13.47%	-9.24%	-7.39%	-10.55%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.